Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135


Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel.

Yokom DW, Stewart J, Alimohamed NS, Winquist E, Berry S, Hubay S, Lattouf JB, Leonard H, Girolametto C, Saad F, Sridhar SS.

Can Urol Assoc J. 2018 Apr 6. doi: 10.5489/cuaj.5108. [Epub ahead of print]


Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.

Lewis RJ, Angus DC, Laterre PF, Kjølbye AL, van der Meulen E, Blemings A, Graves T, Russell JA, Carlsen JE, Jacobsen K, Yealy DM, Opal SM, Windeløv NA, François B, Perner A, Pickkers P, Berry SM.

Ann Am Thorac Soc. 2018 Feb;15(2):250-257. doi: 10.1513/AnnalsATS.201708-669SD.


miFAST: A novel and rapid microRNA target capture method.

Poenitzsch Strong AM, Berry SM, Beebe DJ, Li JL, Spiegelman VS.

Mol Carcinog. 2018 Apr;57(4):559-566. doi: 10.1002/mc.22780. Epub 2018 Feb 12.


Disruption of an RNA-binding hinge region abolishes LHP1-mediated epigenetic repression.

Berry S, Rosa S, Howard M, Bühler M, Dean C.

Genes Dev. 2017 Nov 1;31(21):2115-2120. doi: 10.1101/gad.305227.117. Epub 2017 Dec 6.


A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis.

Abrahao ABK, Ko YJ, Berry S, Chan KKW.

Clin Colorectal Cancer. 2017 Nov 21. pii: S1533-0028(17)30105-6. doi: 10.1016/j.clcc.2017.10.016. [Epub ahead of print]


RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNA.

Pezzi HM, Berry SM, Beebe DJ, Striker R.

Integr Biol (Camb). 2017 Nov 13;9(11):876-884. doi: 10.1039/c7ib00112f.


Distinct phases of Polycomb silencing to hold epigenetic memory of cold in Arabidopsis.

Yang H, Berry S, Olsson TSG, Hartley M, Howard M, Dean C.

Science. 2017 Sep 15;357(6356):1142-1145. doi: 10.1126/science.aan1121. Epub 2017 Aug 17.


Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C.

JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105.


Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer.

Karim S, Brennan K, Nanji S, Berry SR, Booth CM.

JAMA Oncol. 2017 Oct 1;3(10):1386-1392. doi: 10.1001/jamaoncol.2017.1016.


Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods.

Jovin TG, Saver JL, Ribo M, Pereira V, Furlan A, Bonafe A, Baxter B, Gupta R, Lopes D, Jansen O, Smith W, Gress D, Hetts S, Lewis RJ, Shields R, Berry SM, Graves TL, Malisch T, Rai A, Sheth KN, Liebeskind DS, Nogueira RG.

Int J Stroke. 2017 Aug;12(6):641-652. doi: 10.1177/1747493017710341. Epub 2017 Jun 1.


Slow Chromatin Dynamics Allow Polycomb Target Genes to Filter Fluctuations in Transcription Factor Activity.

Berry S, Dean C, Howard M.

Cell Syst. 2017 Apr 26;4(4):445-457.e8. doi: 10.1016/j.cels.2017.02.013. Epub 2017 Mar 22.


Balanced covariates with response adaptive randomization.

Saville BR, Berry SM.

Pharm Stat. 2017 May;16(3):210-217. doi: 10.1002/pst.1803. Epub 2017 Mar 6.


Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada.

Jerzak KJ, Berry S, Ko YJ, Earle C, Chan KK.

Int J Cancer. 2017 May 1;140(9):2162-2167. doi: 10.1002/ijc.30637.


A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgery.

Bennett-Guerrero E, Berry SM, Bergese SD, Fleshner PR, Minkowitz HS, Segura-Vasi AM, Itani KMF, Henderson KW, Rackowski FP, Aberle LH, Stryjewski ME, Corey GR, Allenby KS.

Am J Surg. 2017 Jun;213(6):1003-1009. doi: 10.1016/j.amjsurg.2016.10.007. Epub 2016 Nov 18.


Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.

Svedsater H, Stynes G, Wex J, Frith L, Leather D, Castelnuovo E, Detry M, Berry S.

Asthma Res Pract. 2016 Feb 8;2:4. doi: 10.1186/s40733-015-0016-0. eCollection 2016.


ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.

Gault LM, Lenz RA, Ritchie CW, Meier A, Othman AA, Tang Q, Berry S, Pritchett Y, Robieson WZ.

Alzheimers Res Ther. 2016 Oct 18;8(1):44.


Developing Canadian oncology education goals and objectives for medical students: a national modified Delphi study.

Tam VC, Ingledew PA, Berry S, Verma S, Giuliani ME.

CMAJ Open. 2016 Jul 14;4(3):E359-E364. eCollection 2016 Jul-Sep.


A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancer.

Zhu X, Ko YJ, Berry S, Shah K, Lee E, Chan K.

Gastric Cancer. 2017 Jul;20(4):646-654. doi: 10.1007/s10120-016-0656-7. Epub 2016 Oct 8.


Magnetic System for Automated Manipulation of Paramagnetic Particles.

Guckenberger DJ, Pezzi HM, Regier MC, Berry SM, Fawcett K, Barrett K, Beebe DJ.

Anal Chem. 2016 Oct 3. [Epub ahead of print]


The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.

Bateman RJ, Benzinger TL, Berry S, Clifford DB, Duggan C, Fagan AM, Fanning K, Farlow MR, Hassenstab J, McDade EM, Mills S, Paumier K, Quintana M, Salloway SP, Santacruz A, Schneider LS, Wang G, Xiong C; DIAN-TU Pharma Consortium for the Dominantly Inherited Alzheimer Network.

Alzheimers Dement. 2017 Jan;13(1):8-19. doi: 10.1016/j.jalz.2016.07.005. Epub 2016 Aug 29.

Supplemental Content

Loading ...
Support Center